Successfully Translate a Non-Hallucinogenic Seretonergic Receptor Space from Discovery to the Clinic
Time: 1:45 pm
day: Conference Day Two
Details:
- Harnessing AI and medicinal chemistry to identify a highly selective lead candidate
- Utilizing non-traditional models, including EEG parameters, with strong translational validity to streamline preclinical testing
